WIN-Partners Co., Ltd. (TYO:3183)
1,422.00
-11.00 (-0.77%)
Feb 16, 2026, 3:30 PM JST
WIN-Partners Market Cap
WIN-Partners has a market cap or net worth of 39.5 billion as of February 13, 2026. Its market cap has increased by 6.38% in one year.
Market Cap
39.50B
Enterprise Value
24.61B
Revenue
87.25B
Ranking
n/a
PE Ratio
18.74
Stock Price
1,422.00
Market Cap Chart
Since April 1, 2013, WIN-Partners's market cap has increased from 11.71B to 39.50B, an increase of 237.19%. That is a compound annual growth rate of 9.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 16, 2026 | 39.50B | 5.95% |
| Dec 30, 2025 | 37.28B | -4.59% |
| Dec 30, 2024 | 39.07B | 14.36% |
| Dec 29, 2023 | 34.16B | 12.77% |
| Dec 30, 2022 | 30.30B | 6.06% |
| Dec 30, 2021 | 28.56B | -19.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 15.26T |
| HOYA Corporation | 9.51T |
| Takeda Pharmaceutical Company | 8.87T |
| Otsuka Holdings | 5.59T |
| Healios K.K. | 43.51B |
| Elan Corporation | 42.64B |
| YAKUODO HOLDINGS | 41.04B |
| Daito Pharmaceutical | 39.94B |